🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Pallavi Madhiraju

26672 posts
Pallavi has been a news reporter since 2004 writing for several websites, covering various subjects.
Read More

Could Datroway become AstraZeneca and Daiichi Sankyo’s next major oncology franchise after Enhertu?

atroway has received a positive European regulatory recommendation for first-line treatment of metastatic triple-negative breast cancer in patients unable to receive immunotherapy. The decision moves AstraZeneca PLC and Daiichi Sankyo Company, Limited closer to opening a commercially important market while increasing the strategic value of their antibody drug conjugate partnership.